MDM2 antagonists overcome intrinsic resistance to CDK4/6 inhibition by inducing p21
Anna E. Vilgelm(The Ohio State University), Ann Richmond(Monroe Carell Jr. Children's Hospital), Chi Yan(Vanderbilt University), Ashlyn Blevins(Vanderbilt University), Mark C. Kelley(Vanderbilt University), Douglas B. Johnson(Vanderbilt University Medical Center), Rondi M. Kauffmann(Vanderbilt University), Gregory D. Ayers(Vanderbilt University Medical Center), Kelsie Riemenschneider(The University of Texas Southwestern Medical Center), Rami N. Al‐Rohil(Duke University), Sheau‐Chiann Chen(Vanderbilt University Medical Center), Nabil Saleh(Ain Shams University), Jinming Yang(Hershey (United States)), Christopher Andrew Johnson(Vanderbilt University), Rebecca L. Shattuck-Brandt(Vanderbilt University), Lauren Slesur(Vanderbilt University), Ensar Halilovic(Memorial Sloan Kettering Cancer Center)
Cited by 135
Related Papers
Fulminant Myocarditis with Combination Immune Checkpoint Blockade
|New England Journal of Medicine|2016|2.3k
Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma
|New England Journal of Medicine|2017|1.4k
Abrogation of TGFβ Signaling in Mammary Carcinomas Recruits Gr-1+CD11b+ Myeloid Cells that Promote Metastasis
|Cancer Cell|2008|917